EMA Urges Industry to Expand Focus on Genomic Data in Pharmacovigilance Plans

Drug Industry Daily
A A
European regulators want drugmakers to develop pharmacovigilance plans that include tracking pharmacogenomic data to assess drug safety risks that may apply only to small patient populations.

To View This Article:

Login

Subscribe To Drug Industry Daily